Cogent Biosciences COGT
NASDAQ COGT
$31.94 +0.28 (+0.88%)
As of: Sep 30, 2026 · 9:45 AM EDT

Cogent Biosciences (COGT) Total Debt (2025)

Updated

Cogent Biosciences (COGT) posted Total Debt of $44.25 million for Q3 2025, up 0.7% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Total Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Cogent Biosciences 5.47 Bn 5.47 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 44.25 Mn
Jun 30, 2025 43.95 Mn
API Access

Cogent Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=COGT&period=max&api_key=YOUR_API_KEY